Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3D-Printed Portable Coffin-Like Capsule for Use in Assisted Suicide Granted Approval in Switzerland

By HospiMedica International staff writers
Posted on 07 Dec 2021

A 3D-printed capsule designed for use in assisted suicide may legally be operated in Switzerland. More...

Exit International (Darwin, Australia) has developed the ‘Sarco’ machine which offers a different approach for a peaceful death, without the need for controlled substances. Some 1,300 people died by assisted suicide in Switzerland in 2020 using the services of the country’s two largest assisted suicide organizations. The method currently in use is ingestion of liquid sodium pentobarbital. In contrast, the coffin-like Sarco capsule is activated from the inside by the person intending to die by flooding the interior with nitrogen, rapidly reducing the oxygen level to 1% from 21%. The person feels slightly disoriented and euphoric before losing consciousness. Death takes place through hypoxia and hypocapnia, oxygen and carbon dioxide deprivation, respectively. There is no panic, no choking feeling and the whole process takes about 30 seconds.

Currently, a doctor or doctors need to be involved to prescribe the sodium pentobarbital and to confirm the person’s mental capacity. Sarco aims to remove any kind of psychiatric review from the process and allow the individual to control the method themselves. They will be asked a number of questions and when they have answered, they may press the button inside the capsule activating the mechanism in their own time. The company aims to develop an artificial intelligence screening system to establish the person’s mental capacity and its original conceptual idea is that the person would do an online test and receive a code to access the Sarco.

“Last year, we sought senior advice on the legality of using Sarco in Switzerland for assisted dying and were pleased when the Sarco suicide capsule ‘passes legal review’ in Switzerland,” Dr. Philip Nitschke, founder of Exit International said to SWI swissinfo.ch. “This review has been completed and we’re very pleased with the result which found that we hadn’t overlooked anything. There are no legal issues at all.”

Related Links:
Exit International 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.